Development of paclitaxel-loaded liposomal nanocarrier stabilized by triglyceride incorporation

Development of paclitaxel-loaded liposomal nanocarrier stabilized by triglyceride incorporation

Soon-Seok Hong,1 Ju Yeon Choi,2 Jong Oh Kim,2 Mi-Kyung Lee,3 So Hee Kim,4 Soo-Jeong Lim1 1Department of Bioscience and Bioengineering, Sejong University, Seoul, 2College of Pharmacy, Yeungnam University, Gyeongsan, 3College of Pharmacy, Woosuk University, Wanju-gun, Jeollabuk-do, 4College of Pharma...

Full description

Bibliographic Details
Main Authors:	Hong SS, Choi JY, Kim JO, Lee MK, Kim SH, Lim SJ
Format:	Article
Language:	English
Published:	Dove Medical Press 2016-09-01
Series:	International Journal of Nanomedicine
Subjects:	paclitaxel triglyceride PEGylation liposome stability formulation
Online Access:	https://www.dovepress.com/development-of-paclitaxel-loaded-liposomal-nanocarrier-stabilized-by-t-peer-reviewed-article-IJN

Similar Items

Paclitaxel antitumor effect improvement in lung cancer and prevention of the painful neuropathy using large pegylated cationic liposomes
by: Julia Jiménez-López, et al.
Published: (2021-01-01)

Liposomal paclitaxel induces apoptosis, cell death, inhibition of migration capacity and antitumoral activity in ovarian cancer
by: Raquel Santos Faria, et al.
Published: (2021-10-01)

Enhancement of radiotherapy efficacy by pleiotropic liposomes encapsulated paclitaxel and perfluorotributylamine
by: Xing Jiang, et al.
Published: (2017-01-01)

Evaluation of Pegylated Liposomal Doxorubicin in the Treatment Of Both Platinum- and Paclitaxel-Refractory Epithelial Ovarian Cancer
by: Hao Lin, et al.
Published: (2004-09-01)

Efficacy of chemotherapeutics in classic and non-classic Kaposi sarcoma: A single-center retrospective real-world data
by: Sibel Oyucu Orhan, et al.
Published: (2021-02-01)

Evaluation of the tumor load and adverse reactions of nedaplatin combined with paclitaxel liposome and with paclitaxel treatment of advanced esophageal cancer
by: Jun-Ying Liang1, et al.
Published: (2017-04-01)

Comparison of Efficacy and Safety Between Liposome-paclitaxel plus Carboplatin and Paclitaxel plus Carboplatin on Epithelial Ovarian Cancer
by: HOU Wenjie, et al.
Published: (2018-06-01)

A Radomized Clinical Trial on the Clinical Efficacy and Toxicities of Single-agent Paclitaxel Liposome versus Paclitaxel Liposome plus Oxaliplatin as First-line  Chemotherapy for Advanced Non-small Cell Lung Cancer in Elderly Patients
by: Xiaomei ZENG, et al.
Published: (2012-02-01)

Enhanced delivery of paclitaxel liposomes using focused ultrasound with microbubbles for treating nude mice bearing intracranial glioblastoma xenografts
by: Shen Y, et al.
Published: (2017-08-01)

Effect of PEGylation on the physicochemical and pharmacokinetic characteristics of bovine serum albumin-encapsulated liposome
by: Yuko Okamoto, et al.
Published: (2016-02-01)

Dual Targeting Biomimetic Liposomes for Paclitaxel/DNA Combination Cancer Treatment
by: Guo-Xia Liu, et al.
Published: (2014-08-01)

Improving the anti-keloid outcomes through liposomes loading paclitaxel–cholesterol complexes
by: Wang MJ, et al.
Published: (2019-02-01)

Evaluation of treatments for HIV-associated Kaposi sarcoma in Africa
by: Susan E. Krown, et al.
Published: (2021-04-01)

Clinical Efficacy of Liposomal Paclitaxel in Maintenance Treatment of Patients with Advanced Squamous Cell Lung Carcinoma
by: SHAO Jianghe, et al.
Published: (2018-08-01)

Inhalable PEGylated Phospholipid Nanocarriers and PEGylated Therapeutics for Respiratory Delivery as Aerosolized Colloidal Dispersions and Dry Powder Inhalers
by: Priya Muralidharan, et al.
Published: (2014-06-01)

Liposomal paclitaxel versus docetaxel in induction chemotherapy using Taxanes, cisplatin and 5-fluorouracil for locally advanced nasopharyngeal carcinoma
by: Sai-Lan Liu, et al.
Published: (2018-12-01)

Development, Characterization and In Vitro Evaluation of Paclitaxel and Anastrozole Co-Loaded Liposome
by: Minh Thanh Vu, et al.
Published: (2020-09-01)

A Randomized Trial of Liposomal Paclitaxel plus Cisplatin as First-line Therapy for Advanced Non-small Cell Lung Cancer
by: Xi LI, et al.
Published: (2012-04-01)

DHP107, a novel oral paclitaxel formulation induces less peripheral neuropathic pain and pain-related molecular alteration than intravenous paclitaxel preparation in rat
by: Md. Mahbubur Rahman, et al.
Published: (2019-08-01)

In Vitro Assessment of Magnetic Liposomal Paclitaxel Nanoparticles as a Potential Carrier for the Treatment of Ovarian Cancer
by: Sara Yousefi Aldashi, et al.
Published: (2021-02-01)

Remote loading paclitaxel–doxorubicin prodrug into liposomes for cancer combination therapy
by: Jiang Yu, et al.
Published: (2020-09-01)

Enhanced Efficacy of PEGylated Liposomal Cisplatin: In Vitro and In Vivo Evaluation
by: Mohsen Ghaferi, et al.
Published: (2020-01-01)

Efficient Anti-Glioma Therapy Through the Brain-Targeted RVG15-Modified Liposomes Loading Paclitaxel-Cholesterol Complex
by: Xin X, et al.
Published: (2021-08-01)

Place of pegylated liposomal doxorubicin in the therapy of metastatic breast cancer
by: E. V. Artamonova
Published: (2016-09-01)

Improved Antitumor Efficacy and Pharmacokinetics of Bufalin via PEGylated Liposomes
by: Jiani Yuan, et al.
Published: (2017-11-01)

Towards the Development of Long Circulating Phosphatidylserine (PS)- and Phosphatidylglycerol (PG)-Enriched Anti-Inflammatory Liposomes: Is PEGylation Effective?
by: Miriam E. Klein, et al.
Published: (2021-02-01)

Preparation and in vitro evaluation of an acidic environment-responsive liposome for paclitaxel tumor targeting
by: Lianqin Wang
Published: (2017-09-01)

The Preparation, Determination of a Flexible Complex Liposome Co-Loaded with Cabazitaxel and β-Elemene, and Animal Pharmacodynamics on Paclitaxel-Resistant Lung Adenocarcinoma
by: Yi-Ying Zeng, et al.
Published: (2019-04-01)

Enhanced anticancer efficacy of paclitaxel through multistage tumor-targeting liposomes modified with RGD and KLA peptides
by: Sun J, et al.
Published: (2017-02-01)

Fabrication and characterization of sterically stabilized liposomes of topotecan
by: Dasharath Patel, et al.
Published: (2020-11-01)

Preparation and evaluation of cyclodextrin polypseudorotaxane with PEGylated liposome as a sustained release drug carrier
by: Kayoko Hayashida, et al.
Published: (2014-11-01)

Atypical case of hand foot syndrome due to pegylated liposomal doxorubicin presenting as hyperpigmentation
by: Manjeet Naresh Ramteke, et al.
Published: (2015-01-01)

An Open-Label Study of Pegylated Liposomal Doxorubicin, Vincristine, and Reduced-Dose Dexamethasone Combination Therapy in Newly Diagnosed Multiple Myeloma Patients in the Chinese Population
by: Yang SHEN, Zhixiang SHEN, Bin JIANG, et al.
Published: (2009-12-01)

The Basement Membrane in a 3D Breast Acini Model Modulates Delivery and Anti-Proliferative Effects of Liposomal Anthracyclines
by: Tabea Wiedenhoeft, et al.
Published: (2020-09-01)

Regulation of in vivo behavior of TAT-modified liposome by associated protein corona and avidity to tumor cells
by: Amin M, et al.
Published: (2018-11-01)

Preparation, Characterization, and Pharmacokinetic Study of a Novel Long-Acting Targeted Paclitaxel Liposome with Antitumor Activity
by: Han B, et al.
Published: (2020-01-01)

Ultrasound-Triggered Effects of the Microbubbles Coupled to GDNF Plasmid-Loaded PEGylated Liposomes in a Rat Model of Parkinson's Disease
by: Peijian Yue, et al.
Published: (2018-04-01)

Comparative colloidal stability, antitumor efficacy, and immunosuppressive effect of commercial paclitaxel nanoformulations
by: Jun Ye, et al.
Published: (2021-07-01)

Mechanistic study of decreased skin penetration using a combination of sonophoresis with sodium fluorescein-loaded PEGylated liposomes with D-limonene
by: Rangsimawong W, et al.
Published: (2015-12-01)

Exploring the Use of Pegylated Liposomal Doxorubicin (Caelyx®) as Pressurized Intraperitoneal Aerosol Chemotherapy
by: Manuela Robella, et al.
Published: (2019-06-01)